Accordingly, we demonstrated GBM-derived CSC are sensitive to glycolytic inhibition, and shed light on the therapeutic potential of LDH-A inhibitors in this types of tumour, which is characterised by a poor prognosis. Here, LDHA is linked to neoplasm.